Thinh Q. Pham

A Central Role for HER3 in <i>HER2</i> -Amplified Breast Cancer: Implications for Targeted Therapy

Si Tuen Lee-Hoeflich, Lisa Crocker, Evelyn Yao et al. · Cancer Research · 2008 · 642 citations · Full text

Epithelial versus Mesenchymal Phenotype Determines <i>In vitro</i> Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients

Robert L. Yauch, Thomas Januario, David A. Eberhard et al. · Clinical Cancer Research · 2005 · 489 citations · Full text

Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status

Michael S. Gordon, Daniela Matei, Carol Aghajanian et al. · Journal of Clinical Oncology · 2006 · 249 citations

Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure

Cristi L. Galindo, Michael A. Skinner, Mounir Errami et al. · BMC Physiology · 2009 · 103 citations · Full text

Oncogenic Activating Mutations Are Associated with Local Copy Gain

Barmak Modrek, Lin Ge, Ajay Pandita et al. · Molecular Cancer Research · 2009 · 65 citations

Local Copy Gain, Somatic Variant, Oncogenic Agent +14